Doxorubicin in Next-Generation Cancer Models: Mechanisms,...
2025-10-21
Explore the advanced role of Doxorubicin, a leading DNA topoisomerase II inhibitor, in cancer research using iPSC-derived models and AI-driven toxicity screening. This article uniquely integrates mechanistic detail, high-throughput experimental design, and future-ready phenotypic analysis.